Page 32 - 2023-02-中国全科医学
P. 32

2023年1月   第26卷   第2期                                 http: //www.chinagp.net   E-mail: zgqkyx@chinagp.net.cn  ·153·

               a meta-analysis of randomized controlled trials[J]. Int J Cardiol,  [36]JADAD A R,MOORE R A,CARROLL D,et al. Assessing
               2018,252:63-67. DOI:10.1016/j.ijcard.2017.07.041.    the quality of reports of randomized clinical trials:is blinding
           [27]LEVETT J Y,WINDLE S B,FILION K B,et al. Meta-analysis of   necessary?[J]. Control Clin Trials,1996,17(1):1-12.
               complete versus culprit-only revascularization in patients with ST-  DOI:10.1016/0197-2456(95)00134-4.
               segment elevation myocardial infarction and multivessel coronary   [37]CADORE J C,FURTADO M V,TUMELERO R,et al. Complete
               disease[J]. Am J Cardiol,2020,135:40-49. DOI:10.1016/j.  revascularization versus treatment of the culprit artery only in ST
               amjcard.2020.08.030.                                 elevation myocardial infarction:a multicenter registry[J].
           [28]OSMAN M,KHAN S U,FARJO P D,et al. Meta-analysis      Arq  Bras  Cardiol,2020,115(2):229-237.  DOI:
               comparing complete versus infarct-related artery revascularization   10.36660/abc.20180346.
               in patients with ST-elevation myocardial infarction and multivessel   [38]NAGARAJA V,KALRA A,PURI R S. When to use intravascular
               coronary disease[J]. Am J Cardiol,2020,125(4):513-   ultrasound or optical coherence tomography during percutaneous
               520. DOI:10.1016/j.amjcard.2019.11.017.              coronary intervention? [J]. Cardiovasc Diagn Ther,2020,10(5):
           [29]SEKERCIOGLU N,SPENCER F A,LOPES L C,et al. Culprit   1429-1444. DOI:10.21037/cdt-20-206.
               vessel only vs immediate complete revascularization in patients   [39]BOSSARD  M,MEHTA  S  R.  Complete  or  incomplete
               with acute ST-segment elevation myocardial infarction:systematic   revascularization for ST-segment elevation myocardial infarction:
               review and meta-analysis[J]. Clin Cardiol,2014,37(12):  the PRAMI trial to COMPLETE[J]. Interv Cardiol Clin,2020,9
               765-772. DOI:10.1002/clc.22333.                      (4):433-440. DOI:10.1016/j.iccl.2020.06.001.
           [30]VILLABLANCA P A,BRICENO D F,MASSERA D,et al.    [40]NEUMANN F J,SOUSA-UVA M. 'Ten commandments' for the
               Culprit-lesion only versus complete multivessel percutaneous   2018 ESC/EACTS guidelines on myocardial revascularization[J].
               intervention in ST-elevation myocardial infarction:a systematic   Eur Heart J,2018,39(42):3759. DOI:10.1093/eurheartj/
               review and meta-analysis of randomized trials[J]. Int J Cardiol,  ehy658.
               2016,220:251-259. DOI:10.1016/j.ijcard.2016.06.098.  [41]任小帅 . STEMI 患者行直接 PCI 治疗是否同期处理多支病变血
           [31]VAIDYA S R,DEVARAPALLY S R,ARORA S. Infarct related   管效果对比[J].  医学理论与实践,2020,33(7):1085-
               artery only versus complete revascularization in ST-segment   1086. DOI:10.19381/j.issn.1001-7585.2020.07.020.
               elevation myocardial infarction and multi vessel disease:a meta-  [42]林苗,赵文涛,张敏霞,等 . 直接经皮冠状动脉介入治疗时同
               analysis[J]. Cardiovasc Diagn Ther,2017,7(1):16-26.   期干预非梗死相关动脉对 ST 段抬高型心肌梗死多支血管病变
               DOI:10.21037/cdt.2016.08.06.                         患者预后影响[J]. 临床军医杂志,2018,46(5):552-555.
           [32]SALIH M,IBRAHIM A M,AL-AKCHAR M,et al. Complete      DOI:10.16680/j.1671-3826.2018.05.12.
               versus culprit-only revascularization in patients presenting with   LIN M,ZHAO W T,ZHANG M X,et al. Prognostic impact of
               ST-segment elevation myocardial infarction:a meta-analysis of   simultaneous non-IRA intervention in patients with ST-segment
               randomized control trials[J]. Cardiovasc Revasc Med,2020,21  elevation myocardial infarction and multivessel disease[J].
               (12):1482-1488. DOI:10.1016/j.carrev.2020.05.019.    Clinical Journal of Medical Officers,2018,46(5):552-555.
           [33]ANANTHA  NARAYANAN  M,REDDY  Y  N,SUNDARAM           DOI:10.16680/j.1671-3826.2018.05.12.
               V,et al. What is the optimal approach to a non- culprit stenosis   [43]《中国冠状动脉血流储备分数测定技术临床路径专家共识》
               after ST-elevation myocardial infarction - conservative therapy or   专家组 . 中国冠状动脉血流储备分数测定技术临床路径专家共
               upfront revascularization? An updated meta-analysis of randomized   识[J].  中国介入心脏病学杂志,2019,27(3):121-133.
               trials[J]. Int J Cardiol,2016,216:18-24. DOI:10.1016/j.  DOI:10.3969/j.issn.1004-8812.2019.03.001.
               ijcard.2016.04.054.                             [44]PIJLS N H J,VAN SCHAARDENBURGH P,MANOHARAN
           [34]XU H Y,ZHANG X W,LI J J,et al. Complete versus culprit-only   G,et al. Percutaneous coronary intervention of functionally
               revascularization in patients with ST-segment elevation myocardial   nonsignificant  stenosis:5-year  follow-up  of  the  DEFER
               infarction and multivessel disease:a meta-analysis of randomized   study[J]. J Am Coll Cardiol,2007,49(21):2105-2111.
               trials[J]. BMC Cardiovasc Disord,2019,19(1):91. DOI:  DOI:10.1016/j.jacc.2007.01.087.
               10.1186/s12872-019-1073-8.                      [45]TONINO P A,DE BRUYNE B,PIJLS N H,et al. Fractional
           [35]WOOD L,EGGER M,GLUUD L L,et al. Empirical evidence   flow reserve versus angiography for guiding percutaneous coronary
               of bias in treatment effect estimates in controlled trials with   intervention[J]. N Engl J Med,2009,360(3):213-224.
               different interventions and outcomes:meta-epidemiological   DOI:10.1056/NEJMoa0807611.
               study[J].  BMJ,2008,336(7644):601-605.  DOI:               (收稿日期:2022-04-25;修回日期:2022-08-02)
               10.1136/bmj.39465.451748.AD.                                                    (本文编辑:宋春梅)
   27   28   29   30   31   32   33   34   35   36   37